Next Article in Journal
New Piperazine Derivatives of 6-Acetyl-7-hydroxy-4-methylcoumarin as 5-HT1A Receptor Agents
Next Article in Special Issue
From the Catastrophic Objective Irreproducibility of Cancer Research and Unavoidable Failures of Molecular Targeted Therapies to the Sparkling Hope of Supramolecular Targeted Strategies
Previous Article in Journal
Therapeutic Use and Molecular Aspects of Ivabradine in Cardiac Remodeling: A Review
Previous Article in Special Issue
Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid Tumors
 
 
Review

Article Versions Notes

Int. J. Mol. Sci. 2023, 24(3), 2805; https://doi.org/10.3390/ijms24032805
Action Date Notes Link
article pdf uploaded. 1 February 2023 13:19 CET Version of Record https://www.mdpi.com/1422-0067/24/3/2805/pdf-vor
article xml file uploaded 3 February 2023 07:25 CET Original file -
article xml uploaded. 3 February 2023 07:25 CET Update https://www.mdpi.com/1422-0067/24/3/2805/xml
article pdf uploaded. 3 February 2023 07:25 CET Updated version of record https://www.mdpi.com/1422-0067/24/3/2805/pdf
article html file updated 3 February 2023 07:26 CET Original file -
article html file updated 1 March 2023 12:09 CET Update https://www.mdpi.com/1422-0067/24/3/2805/html
Back to TopTop